Navigation Links
New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge
Date:6/7/2012

FARMINGTON, Conn., June 4, 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased to announce the immediate availability of a new report and new research tool for cancer drug research and development companies and market analysts:

Oncology Drug Pathway Analyzer

Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. The Oncology Drug Pathway Analyzer from BioSeeker Group AB is an interactive data tool to analyze thousands drug-pathway connections in close to 90 different cancer indications. This tool allows users to examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.).

With the Oncology Drug Pathway Analyzer, users can review their competition and find suitable benchmarking drugs, basing their search on specific pathways and drug properties. This will allow companies to uncover potential indication expansion areas for their drug portfolios, reveal repositioning opportunities for their older, shelved drugs, and evaluate the progression and success of targeting certain pathways for the treatment of cancer. This tool will also help users investigate different therapy combination options available for various cancer types, and reveal for the most-efficient ways to combine their drugs with other targeted agents.

A detailed description of the tool and a real case scenario are available at http://www.giiresearch.com/report/bg243231-oncology-drug-pathway-analyzer-premium-version.html

Cancer Treatment Drugs Markets in China

As China's continued rise as a modern economy proves to be a significant growth sector, demand for cancer treatment drugs across their nation has grown at a quick pace over the past decade, with both production and demand forecast to continue to this steady growth in the next five years.

Now, Global Information is pleased to make available a collection of 12 complete cancer drug market research reports from Asia Market Information & Development on the Chinese Cancer treatment drugs market, covering the following cancers: lung cancer, breast cancer, prostate cancer, leukemia, ovrian cancer, colon cancer, cevical cancer, brain cancer, bladder cancer, liver cancer, kidney cancer, and skin cancer treatment drugs.

The reports include market trends, developments, with market forecasts through 2016 and 2021.

A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/amid243405-cancer-treatment-drugs-markets-china-12-full.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Worlds largest release of comprehensive human cancer genome data helps speed discoveries
2. New musical pacifier helps premature babies get healthy
3. Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
4. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
5. Gene signature helps identify risk of relapse in lung cancer patients
6. New analysis helps guide use of erlotinib in advanced non-small cell lung cancer
7. University of Minnesota invention helps advance reliability of alternative energy
8. New iPad, iPhone app helps mariners avoid endangered right whales
9. Newly found protein helps cells build tissues
10. Protein jailbreak helps breast cancer cells live
11. Computer sleuthing helps unravel RNAs role in cellular function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... focused on quality, regulatory and technical consulting, provides a free webinar ... presented on July 13, 2016 at 12pm CT at no charge. , Incomplete ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
(Date:6/22/2016)... 22, 2016 Cell Applications, Inc. and ... to produce up to one billion human induced ... one week. These high-quality, consistent stem cells enable ... and spend more time doing meaningful, relevant research. ... high-volume manufacturing process that produces affordable, reliable HiPSC ...
Breaking Biology Technology: